Form 8-K - Current report:
SEC Accession No. 0001171843-20-000105
Filing Date
2020-01-07
Accepted
2020-01-07 16:05:15
Documents
3
Period of Report
2020-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_010720.htm 8-K 29855
2 EXHIBIT 2.1 exh_21.htm EX-2.1 669980
3 EXHIBIT 2.2 exh_22.htm EX-2.2 554874
  Complete submission text file 0001171843-20-000105.txt   1256000
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 20513375
SIC: 3841 Surgical & Medical Instruments & Apparatus